Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lundstedt

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Drug Development and Industrial Pharmacy|March 30, 2000
Multivariate methods in developing an evolutionary strategy for tablet formulationJ Gabrielsson, A Nyström, T Lundstedt
International Journal of Food Microbiology|February 16, 2002
Detection and quantification of ochratoxin A and deoxynivalenol in barley grains by GC-MS and electronic noseJ Olsson, T Börjesson, T Lundstedt, et al.
International Journal of Food Microbiology|October 6, 2000
Volatiles for mycological quality grading of barley grains: determinations using gas chromatography-mass spectrometry and electronic noseJ Olsson, T Börjesson, T Lundstedt, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 22, 2006
Neuroprotective effects of melanocortins in experimental spinal cord injury. An experimental study in the rat using topical application of compounds with varying affinity to melanocortin receptorsH S Sharma, A Skottner, T Lundstedt, et al.
Drug Development and Industrial Pharmacy|February 23, 2002
Investigation of flow properties of powders by means of a uniaxial tester, in relation to direct tablet compressionN O Lindberg, A Berdal, G Enstad, et al.
Biochimica Et Biophysica Acta|May 9, 2001
Development of proteo-chemometrics: a novel technology for the analysis of drug-receptor interactionsM Lapinsh, P Prusis, A Gutcaits, et al.
Current Pharmaceutical Design|July 14, 2007
Neuroprotective effects of melanocortins in CNS injuryH S Sharma, T Lundstedt, M Flärdh, et al.
Biochimica Et Biophysica Acta|May 9, 2001
PLS modeling of chimeric MS04/MSH-peptide and MC1/MC3-receptor interactions reveals a novel method for the analysis of ligand-receptor interactionsP Prusis, R Muceniece, P Andersson, et al.
Acta Neurochirurgica. Supplement|February 3, 2004
Low molecular weight compounds with affinity to melanocortin receptors exert neuroprotection in spinal cord injury--an experimental study in the ratH S Sharma, T Lundstedt, M Flärdh, et al.
Annals of the New York Academy of Sciences|July 10, 2003
Anti-inflammatory potential of melanocortin receptor-directed drugsA Skottner, C Post, A Ocklind, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Drug Development and Industrial Pharmacy|March 30, 2000
Multivariate methods in developing an evolutionary strategy for tablet formulationJ Gabrielsson, A Nyström, T Lundstedt
International Journal of Food Microbiology|February 16, 2002
Detection and quantification of ochratoxin A and deoxynivalenol in barley grains by GC-MS and electronic noseJ Olsson, T Börjesson, T Lundstedt, et al.
International Journal of Food Microbiology|October 6, 2000
Volatiles for mycological quality grading of barley grains: determinations using gas chromatography-mass spectrometry and electronic noseJ Olsson, T Börjesson, T Lundstedt, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 22, 2006
Neuroprotective effects of melanocortins in experimental spinal cord injury. An experimental study in the rat using topical application of compounds with varying affinity to melanocortin receptorsH S Sharma, A Skottner, T Lundstedt, et al.
Drug Development and Industrial Pharmacy|February 23, 2002
Investigation of flow properties of powders by means of a uniaxial tester, in relation to direct tablet compressionN O Lindberg, A Berdal, G Enstad, et al.
Biochimica Et Biophysica Acta|May 9, 2001
Development of proteo-chemometrics: a novel technology for the analysis of drug-receptor interactionsM Lapinsh, P Prusis, A Gutcaits, et al.
Current Pharmaceutical Design|July 14, 2007
Neuroprotective effects of melanocortins in CNS injuryH S Sharma, T Lundstedt, M Flärdh, et al.
Biochimica Et Biophysica Acta|May 9, 2001
PLS modeling of chimeric MS04/MSH-peptide and MC1/MC3-receptor interactions reveals a novel method for the analysis of ligand-receptor interactionsP Prusis, R Muceniece, P Andersson, et al.
Acta Neurochirurgica. Supplement|February 3, 2004
Low molecular weight compounds with affinity to melanocortin receptors exert neuroprotection in spinal cord injury--an experimental study in the ratH S Sharma, T Lundstedt, M Flärdh, et al.
Annals of the New York Academy of Sciences|July 10, 2003
Anti-inflammatory potential of melanocortin receptor-directed drugsA Skottner, C Post, A Ocklind, et al.
Pageof 1